Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the personalized cancer treatment market size evolved in recent years?

The personalized cancer treatment market has grown rapidly and will progress from $181.55 billion in 2024 to $201.57 billion in 2025, achieving a CAGR of 11.0%. Contributing factors to past growth include advancements in genomics and molecular biology, a rising cancer prevalence, increased adoption of personalized medicine, heightened awareness of cancer treatment options, and improved diagnostic and monitoring technologies.

What are the predictions for the personalized cancer treatment market size in the coming years?

The personalized cancer treatment market is set for rapid growth, reaching $303.01 billion by 2029 with a CAGR of 10.7%. Growth is attributed to the expansion of targeted therapies, AI and machine learning advancements, increasing cancer research investments, demand for precision medicine, and new biomarker developments. Key trends include combination therapies, digital health tool integration, liquid biopsy adoption, immunotherapy expansion, and a stronger focus on patient-centric care.

Get your personalized cancer treatment market report here!

https://www.thebusinessresearchcompany.com/report/personalized-cancer-treatment-global-market-report

What key factors are fueling the growth of the personalized cancer treatment market?

The increasing prevalence of cancer is expected to drive the growth of the personalized cancer treatment market. The rise in cancer cases is mainly due to longer life expectancies and exposure to risk factors like tobacco, alcohol, and obesity. Personalized cancer treatments offer targeted therapies for various cancer types, leading to better patient outcomes, thus boosting investment in precision medicine. For example, in February 2024, the World Health Organization projected a 77% increase in new cancer cases globally, reaching over 35 million by 2050 compared to 20 million in 2022. Therefore, the growing cancer burden is fueling the personalized cancer treatment market.

How is the global personalized cancer treatment market divided into key segments?

The personalized cancer treatmentmarket covered in this report is segmented –

1) By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type

2) By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types

4) By End-Users: Hospitals And Clinics, Research Institutes, Other End Users

Subsegments:

1) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Angiogenesis Inhibitors, Signal Transduction Inhibitors

2) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines, Monoclonal Antibodies For Immunotherapy

3) By Hormone Therapy: Anti-Estrogens, Aromatase Inhibitors, Progestins, LHRH Agonists

4) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Taxanes

5) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Brachytherapy, Radioimmunotherapy, Stereotactic Radiosurgery (SRS)

6) By Other Treatment Types: Gene Therapy, Stem Cell Transplantation, Metabolic Therapy, Nanomedicine

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19135&type=smp

Who are the key firms paving the way for growth in the personalized cancer treatment market?

Major companies operating in the personalized cancer treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma

Which trends are expected to transform the personalized cancer treatment market?

Leading firms in the personalized cancer treatment market are striving to create revolutionary solutions, like artificial intelligence (AI) integrated multimodal immune profile algorithmic examinations, to forecast patient’s reactions to immunotherapy and boost personalized treatment approaches. Such AI-powered algorithmic tests evaluate numerous sorts of data, comprising genomic, transcriptomic, and clinical biomarkers, to measure a patient’s immune profile and prognosticate their response to immunotherapy, thus assisting patients segmentation and directing personalized cancer treatments. For example, in July 2024, Tempus AI, Inc., a healthcare technology firm in the US, introduced its AI-integrated multimodal immune profile algorithmic test (IPS), marking its initial entrance into the field of immunotherapy diagnostics. The test, solely for research utilization (RUO), evaluates various immunotherapy-related biomarkers to generate a score that can forecast a patient’s reaction to immunotherapy, thus aiding personalized cancer treatment. Hence, AI-facilitated immunotherapy targeted diagnostics improve patient segmentation and the choice of treatment in oncology.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19135

What regions are contributing significantly to the growth of the personalized cancer treatment market?

North America was the largest region in the personalized cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

AI In Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Metastatic Breast Cancer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/metastatic-breast-cancer-treatment-global-market-report

Solid Tumor Cancer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: